Evidence map›Paper›PMID 34682236›Full record

ReviewJournal of fungi (Basel, Switzerland)2021

Invasive Fusariosis in Patients with Hematologic Diseases.

Marcio Nucci, Gloria Barreiros, Tiyomi Akiti, Elias Anaissie, Simone A Nouér

Open access · goldAbstract readReview
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Infection and drug resistance · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Clinical Features and Outcomes of InvasiveJournal of fungi (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Review
  12. Acute lymphoblastic leukemia withFrontiers in medicine · 2025
    Article
  13. High azole MICs in Fusarium spp.: a key factor in treatment decisions for cancer patients?Revista do Instituto de Medicina Tropical de Sao Paulo · 2025
    Article
  14. Article
  15. Article
  16. First report of fatal fungemia dueMedical mycology case reports · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Life (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Marcio NucciDepartment of Internal Medicine, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.ORCID 0000-0003-4867-0014
Gloria BarreirosMycology Laboratory, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.
Tiyomi AkitiMycology Laboratory, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.
Elias AnaissieCTI Clinical Trial & Consulting Services, Cincinnati, OH 41011, USA.
Simone A NouérDepartment of Infectious Diseases, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.
Universidade Federal do Rio de Janeiro · BRClinical Trial and Consulting · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

fungal infectionfungemiafusariosisFusariumimmunocompromisedneutropenic

Identifiers

PMID34682236
PMCPMC8537065
OpenAlexW3203797705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.